Transintestinal cholesterol excretion: A secondary, nonbiliary pathway contributing to reverse cholesterol transport
David Q.‐H. Wang, Piero Portincasa, Patrick Tso – 27 June 2017
Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study
Harrys A. Torres, Jeff Hosry, Parag Mahale, Minas P. Economides, Ying Jiang, Anna S. Lok – 27 June 2017 – Hepatitis C virus (HCV) reactivation in patients receiving cancer treatment has been reported in retrospective studies. We sought to determine prospectively the incidence, predictors, and clinical significance of HCV reactivation during cancer treatment. HCV‐infected patients receiving cancer treatment at our institution between November 2012 and July 2016 were studied.
Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer
Quirino Lai, Alessandro Vitale, Samuele Iesari, Armin Finkenstedt, Gianluca Mennini, Gabriele Spoletini, Maria Hoppe‐Lotichius, Giovanni Vennarecci, Tommaso M. Manzia, Daniele Nicolini, Alfonso W. Avolio, Anna Chiara Frigo, Ivo Graziadei, Massimo Rossi, Emmanouil Tsochatzis, Gerd Otto, Giuseppe M.
Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population‐based cohort study
Jonas F. Ludvigsson, Hanns‐Ulrich Marschall, Hannes Hagström, Jonas Höijer, Olof Stephansson – 27 June 2017 – Liver biopsy is an important procedure in the investigation of liver disease. We examined pregnancy outcomes in women who underwent liver biopsy during pregnancy. In a nationwide population‐based cohort study we linked data from the Swedish Medical Birth Registry (for births between 1992 and 2011) with those from the Swedish Patient Registry. We identified 23 pregnancies exposed to liver biopsy.
Adipose‐derived exosomal MicroRNAs orchestrate gene regulation in the liver: Is this the missing link in nonalcoholic fatty liver disease?
Hannelie Korf, Schalk van der Merwe – 27 June 2017
Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study
Harrys A. Torres, Jeff Hosry, Parag Mahale, Minas P. Economides, Ying Jiang, Anna S. Lok – 27 June 2017 – Hepatitis C virus (HCV) reactivation in patients receiving cancer treatment has been reported in retrospective studies. We sought to determine prospectively the incidence, predictors, and clinical significance of HCV reactivation during cancer treatment. HCV‐infected patients receiving cancer treatment at our institution between November 2012 and July 2016 were studied.
Disparities in Eurotransplant liver transplantation wait‐list outcome between patients with and without model for end‐stage liver disease exceptions
Andreas Umgelter, Alexander Hapfelmeier, Wouter Kopp, Marieke van Rosmalen, Xavier Rogiers, Markus Guba, for the Eurotransplant Liver Advisory Committee – 26 June 2017 – The sickest‐first principle in donor‐liver allocation can be implemented by allocating organs to patients with cirrhosis with the highest Model for End‐Stage Liver Disease (MELD) scores. For patients with other risk factors, standard exceptions (SEs) and nonstandard exceptions (NSEs) have been developed.
Con: Acute‐on‐chronic liver failure
John O'Grady – 26 June 2017
A matched pair analysis of multicenter longterm follow‐up after split‐liver transplantation with extended right grafts
Mitchell W. Ross, Matteo Cescon, Roberta Angelico, Enzo Andorno, Giorgio Rossi, Antonio Pinna, Luciano Carlis, Umberto Baccarani, Umberto Cillo, Michele Colledan, Vincenzo Mazzaferro, Giuseppe Tisone, Massimo Rossi, Fabio Tuzzolino, Duilio Pagano, Salvatore Gruttadauria, George Mazariegos, Bruno Gridelli, Marco Spada – 26 June 2017 – Split‐liver transplantation has been proposed as an alternative to whole liver (WL) transplantation to expand the donor pool, but studies comparing adult longterm outcomes between the 2 methods are conflicting and limited.